Literature DB >> 20309708

Muscle ceramide content in man is higher in type I than type II fibers and not influenced by glycogen content.

P Nordby1, C Prats, D Kristensen, K Ekroos, G Forsberg, J L Andersen, T Ploug, F Dela, L Storlien, J W Helge.   

Abstract

Human muscle is studied during glycogen depletion and repletion to understand the influence of exercise and muscle glycogen on total ceramide content. In addition, fiber-type-specific ceramide storage is investigated. Ten healthy males (26.4 +/- 0.9 years, BMI 24.4 +/- 0.7 kg m(-2) and VO2max 57 +/- 2 mL O2 min(-1) kg(-1)) participated in the study. On the first day, one leg was glycogen-depleted (DL) by exhaustive intermittent exercise followed by low carbohydrate diet. Next day, in the overnight fasted condition, muscle biopsies were excised from vastus lateralis before and after exhaustive exercise from both DL and control leg (CL). Muscle glycogen was analyzed biochemically and total muscle ceramide content by 2D quantitative lipidomic approach. Furthermore, fiber-type ceramide content was determined by fluorescence immunohistochemistry. Basal muscle glycogen was decreased (P < 0.05) with 50 +/- 6% in DL versus CL. After exhaustive exercise, muscle glycogen was similar in CL and DL 139 +/- 38 and 110 +/- 31 mmol kg(-1), respectively. Total muscle ceramide 58 +/- 1 pmol mg(-1) was not influenced by glycogen or exercise. Ceramide content was consistently higher (P < 0.001) in type I than in type II muscle fibers. In conclusion, human skeletal muscle, ceramide content is higher in type I than in type II. Despite rather large changes in muscle glycogen induced by prior depletion, exercise to exhaustion and repletion, total muscle ceramide concentration remained unchanged.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309708     DOI: 10.1007/s00421-010-1428-4

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  31 in total

1.  Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning.

Authors:  Christer S Ejsing; Eva Duchoslav; Julio Sampaio; Kai Simons; Ron Bonner; Christoph Thiele; Kim Ekroos; Andrej Shevchenko
Journal:  Anal Chem       Date:  2006-09-01       Impact factor: 6.986

2.  Are substrate use during exercise and mitochondrial respiratory capacity decreased in arm and leg muscle in type 2 diabetes?

Authors:  S Larsen; I Ara; R Rabøl; J L Andersen; R Boushel; F Dela; J W Helge
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

3.  Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles.

Authors:  M Zendzian-Piotrowska; M Baranowski; P Zabielski; J Górski
Journal:  J Physiol Pharmacol       Date:  2006-11       Impact factor: 3.011

4.  Effect of acute exercise on the content of free sphinganine and sphingosine in different skeletal muscle types of the rat.

Authors:  A Dobrzyń; J Górski
Journal:  Horm Metab Res       Date:  2002-09       Impact factor: 2.936

5.  Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise.

Authors:  Agnieszka Dobrzyń; Jan Górski
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-02       Impact factor: 4.310

6.  Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.

Authors:  Agnieszka Dobrzyn; Pawel Dobrzyn; Seong-Ho Lee; Makoto Miyazaki; Paul Cohen; Esra Asilmaz; D Grahame Hardie; Jeffrey M Friedman; James M Ntambi
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-11-23       Impact factor: 4.310

Review 7.  Ceramides in insulin resistance and lipotoxicity.

Authors:  Scott A Summers
Journal:  Prog Lipid Res       Date:  2005-12-19       Impact factor: 16.195

8.  Exercise and training effects on ceramide metabolism in human skeletal muscle.

Authors:  Jørn Wulff Helge; Agnieszka Dobrzyn; Bengt Saltin; Jan Gorski
Journal:  Exp Physiol       Date:  2004-01       Impact factor: 2.969

9.  Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle.

Authors:  Marek Straczkowski; Irina Kowalska; Agnieszka Nikolajuk; Stella Dzienis-Straczkowska; Ida Kinalska; Marcin Baranowski; Malgorzata Zendzian-Piotrowska; Zofia Brzezinska; Jan Gorski
Journal:  Diabetes       Date:  2004-05       Impact factor: 9.461

10.  Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes.

Authors:  M Straczkowski; I Kowalska; M Baranowski; A Nikolajuk; E Otziomek; P Zabielski; A Adamska; A Blachnio; J Gorski; M Gorska
Journal:  Diabetologia       Date:  2007-08-28       Impact factor: 10.122

View more
  4 in total

1.  Skeletal muscle ceramides and relationship with insulin sensitivity after 2 weeks of simulated sedentary behaviour and recovery in healthy older adults.

Authors:  Paul T Reidy; Alec I McKenzie; Ziad Mahmassani; Vincent R Morrow; Nikol M Yonemura; Paul N Hopkins; Robin L Marcus; Matthew T Rondina; Yu Kuei Lin; Micah J Drummond
Journal:  J Physiol       Date:  2018-10-09       Impact factor: 5.182

2.  Muscle ceramide content is similar after 3 weeks' consumption of fat or carbohydrate diet in a crossover design in patients with type 2 diabetes.

Authors:  J W Helge; L Tobin; T Drachmann; L I Hellgren; F Dela; H Galbo
Journal:  Eur J Appl Physiol       Date:  2011-06-22       Impact factor: 3.078

3.  An optimized histochemical method to assess skeletal muscle glycogen and lipid stores reveals two metabolically distinct populations of type I muscle fibers.

Authors:  Clara Prats; Alba Gomez-Cabello; Pernille Nordby; Jesper L Andersen; Jørn W Helge; Flemming Dela; Otto Baba; Thorkil Ploug
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

4.  Training Does Not Alter Muscle Ceramide and Diacylglycerol in Offsprings of Type 2 Diabetic Patients Despite Improved Insulin Sensitivity.

Authors:  Ditte Søgaard; Torben Østergård; Agnieszka U Blachnio-Zabielska; Marcin Baranowski; Andreas Hansen Vigelsø; Jesper Løvind Andersen; Flemming Dela; Jørn Wulff Helge
Journal:  J Diabetes Res       Date:  2016-09-29       Impact factor: 4.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.